Abbott India Limited (ABBOTINDIA.BO)
INR 28764.0
(2.24%)
INR 28764.0
(2.24%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 6.19 Billion INR | -4.51% |
| 2022 | 6.48 Billion INR | -5.67% |
| 2021 | 6.87 Billion INR | -4.15% |
| 2020 | 7.17 Billion INR | 36.12% |
| 2019 | 5.27 Billion INR | -13.12% |
| 2018 | 6.06 Billion INR | 3.67% |
| 2017 | 5.85 Billion INR | 16.92% |
| 2016 | 5 Billion INR | 35.27% |
| 2015 | 3.7 Billion INR | -3.65% |
| 2014 | 3.84 Billion INR | 5.09% |
| 2013 | 3.65 Billion INR | 38.64% |
| 2012 | 2.63 Billion INR | 3.43% |
| 2011 | 2.54 Billion INR | 98.23% |
| 2010 | 1.28 Billion INR | 25.6% |
| 2009 | 1.02 Billion INR | 11.13% |
| 2008 | 921.2 Million INR | 6.63% |
| 2007 | 863.9 Million INR | 57.82% |
| 2006 | 547.4 Million INR | 23.82% |
| 2005 | 442.1 Million INR | 47.81% |
| 2004 | 299.1 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 5.12 Billion INR | 0.0% |
| 2023 Q4 | 6.19 Billion INR | 0.0% |
| 2023 FY | 6.19 Billion INR | -4.51% |
| 2023 Q1 | - INR | -100.0% |
| 2022 Q4 | 6.48 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 7.32 Billion INR | 0.0% |
| 2022 FY | 6.48 Billion INR | -5.67% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 6.87 Billion INR | -4.15% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q4 | 6.87 Billion INR | 0.0% |
| 2021 Q2 | 6.31 Billion INR | 0.0% |
| 2020 Q4 | 7.17 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 6.89 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 7.17 Billion INR | 36.12% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 6.27 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 FY | 5.27 Billion INR | -13.12% |
| 2019 Q4 | 5.27 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 6.06 Billion INR | 3.67% |
| 2018 Q4 | 6.06 Billion INR | 0.0% |
| 2018 Q2 | 5.63 Billion INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 4.63 Billion INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 5.85 Billion INR | 16.92% |
| 2017 Q4 | 5.85 Billion INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q4 | 5 Billion INR | 0.0% |
| 2016 Q2 | 4.76 Billion INR | 0.0% |
| 2016 FY | 5 Billion INR | 35.27% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q2 | 3.43 Billion INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q4 | 3.7 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 FY | 3.7 Billion INR | -3.65% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 3.84 Billion INR | 5.09% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 3.08 Billion INR | 0.0% |
| 2014 Q4 | 3.84 Billion INR | 0.0% |
| 2013 Q4 | 3.65 Billion INR | 0.0% |
| 2013 FY | 3.65 Billion INR | 38.64% |
| 2013 Q2 | - INR | -100.0% |
| 2013 Q1 | 3.27 Billion INR | -16.05% |
| 2012 Q4 | 3.9 Billion INR | 48.0% |
| 2012 FY | 2.63 Billion INR | 3.43% |
| 2012 Q3 | 2.63 Billion INR | 0.0% |
| 2011 FY | 2.54 Billion INR | 98.23% |
| 2011 Q3 | 2.54 Billion INR | 0.0% |
| 2010 FY | 1.28 Billion INR | 25.6% |
| 2009 FY | 1.02 Billion INR | 11.13% |
| 2008 FY | 921.2 Million INR | 6.63% |
| 2007 FY | 863.9 Million INR | 57.82% |
| 2006 FY | 547.4 Million INR | 23.82% |
| 2005 FY | 442.1 Million INR | 47.81% |
| 2004 FY | 299.1 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cipla Limited | 52.37 Billion INR | 88.171% |
| Gland Pharma Limited | 16.55 Billion INR | 62.569% |
| GlaxoSmithKline Pharmaceuticals Limited | 5.33 Billion INR | -16.045% |
| Kopran Limited | 1.38 Billion INR | -347.394% |
| Marksans Pharma Limited | 6.17 Billion INR | -0.265% |
| NGL Fine-Chem Limited | 433.03 Million INR | -1330.788% |
| Pfizer Limited | 4.33 Billion INR | -42.862% |
| Sanofi India Limited | 6.63 Billion INR | 6.662% |
| SMS Pharmaceuticals Limited | 2.33 Billion INR | -165.12% |